South Africa Contraceptive Devices Market Report 2022 to 2030

South Africa Contraceptive Devices Market Analysis

$ 3999

South Africa's contraceptive devices market is expected to from $84 Mn in 2022 to $170 Mn in 2030 with a CAGR of 9.23% for the forecasted year 2022-30. The huge young population in South Africa is fueling demand for more inventive and adaptable contraceptive methods that may accommodate their changing wants and lifestyles. The market is segmented by type and by gender. Some key players in this market include Gabler Medical, Sinapi Biomedical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.

ID: IN10ZAMD005 CATEGORY: Medical Devices GEOGRAPHY: South Africa AUTHOR: Jigyasu Bhandari

Buy Now

South Africa Contraceptive Devices Healthcare Market Executive Analysis

South Africa's contraceptive devices market is expected to from $84 Mn in 2022 to $170 Mn in 2030 with a CAGR of 9.23% for the forecasted year 2022-30. In South Africa, healthcare costs were $648.25 per person in 2022. Between 2018 and 2023, South Africa's health spending per capita decreased by an average of 1.56% per year.

In South Africa, there were 119 maternal deaths per 100,000 live births in 2022. This is more than the average death rate worldwide, which is 211 per 100,000 live births. With an estimated 7.7 million people expected to have the disease by 2021, South Africa has one of the highest rates of HIV/AIDS in the entire world. In adults aged 15 to 49, the prevalence rate is 20.4%. In South Africa, when used appropriately and consistently, contraceptive methods are quite successful at preventing unplanned pregnancies. This can provide better control over family planning decisions and assist individuals and couples avoid the financial and emotional consequences related to unplanned pregnancies. By restricting the interchange of bodily fluids during sexual activity, some contraceptive methods, such as condoms, can also help lower the risk of sexually transmitted infections. Individuals who use contraceptives have more privacy and control over their reproductive health decisions. They are more accessible to people who might not have simple access to healthcare services because they can be used covertly and without the requirement for a healthcare provider.

South Africa Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

The huge young population in South Africa is fueling demand for more inventive and adaptable contraceptive methods that may accommodate their changing wants and lifestyles. The market for contraceptive devices is expanding due to new contraceptive technologies being developed, such as long-acting reversible contraceptives and mobile health applications. Compared to conventional approaches, these new technologies offer better user experience, ease, and effectiveness. In South Africa, especially among younger generations, there is a growing knowledge of and teaching on the advantages of contraception. As a result, there is a growing need for more advanced and efficient contraceptive methods.

Market Restraints

Many people in South Africa still lack a fundamental grasp of the many contraceptive methods available, how to use them, or where to find them, despite the fact that the use of contraception is becoming more commonly known and educated in that country. It might be difficult for manufacturers to distinguish their products and take control of the market given the limited range of contraceptive choices now available in South Africa. Some persons might be discouraged from obtaining and using contraceptive devices because of stigma and cultural prohibitions around their use, especially in rural or conservative cultures.

Competitive Landscape

Key Players

Gabler Medical (SA)
Sinapi Biomedical (SA)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Teva Pharmaceutical

Healthcare Policies and Regulatory Landscape

The South African Health Products Regulatory Authority (SAHPRA), the Department of Health, and the National Health Laboratory Service (NHLS) are a few of the bodies in charge of regulating the healthcare policies and legal framework in South Africa for contraceptive devices. Regulating the licencing, registration, and oversight of contraceptive devices in South Africa is the responsibility of the SAHPRA. To assure its safety, effectiveness, and quality, every contraceptive method sold in the nation must pass a stringent regulatory process. Setting healthcare policies and regulations pertaining to contraceptive devices is the responsibility of the Department of Health. This involves promoting access to a variety of contraceptive choices for all residents and offering family planning services through public health facilities.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.